The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
2026-10-19
The Saudi Food and Drug Authority (SFDA) joined the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) as a Regulatory Member in June 2021. Following that, as the first organization in the Middle East, SFDA became a member of the ICH Management Committee in June 2024, a step that corresponds to the objectives of the Kingdom’s Vision 2030 in enhancing the Kingdom’s position at the international level and achieving leadership in all fields.
In addition, SFDA was elected as a member of the MedDRA Steering Committee in May 2025, reflecting its growing role in global pharmacovigilance and safety terminology governance.
SFDA experts also take an active part in various ICH Expert Working Groups dealing with the quality and safety of medicines, preclinical and clinical requirements, and requirements regarding the content of authorization dossiers.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.